| Literature DB >> 9331948 |
E Martinez-Naves1, L D Barber, J A Madrigal, C M Vullo, C Clayberger, S C Lyu, R C Williams, C Gorodezky, T Markow, M L Petzl-Erler, P Parham.
Abstract
Functional properties of the B*4801 allotype were investigated using HLA class I-deficient 221 cells transfected with B*4801 cDNA. From pool sequence analysis of endogenously bound peptides, B*4801 was shown to select for nonamer peptides having glutamine or lysine at position 2 and leucine at the carboxyl-terminus. In an in vitro cell-cell binding assay, B*4801 binds CD8 alpha homodimers weakly due to the presence of a threonine residue at position 245 in the alpha 3 domain. A mutant B*4801 molecule in which alanine replaces threonine 245, binds CD8 alpha homodimers at levels comparable to those of other HLA class I allotypes. Despite the low affinity of B*4801 for CD8 alpha, alloreactive T-cells that recognize B*4801 molecules expressed by the 221 transfectant are inhibited by anti-CD8 monoclonal antibodies. Analysis of 25 B*48-expressing individuals from various populations showed threonine 245 was encoded by every B*48 allele.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9331948 DOI: 10.1111/j.1399-0039.1997.tb02869.x
Source DB: PubMed Journal: Tissue Antigens ISSN: 0001-2815